Mild persistent asthma | Moderate persistent asthma
Item
patients diagnosed with mild-to-moderate persistent asthma
boolean
C1960046 (UMLS CUI [1])
C1960047 (UMLS CUI [2])
Forced Expiratory Volume in 1 Second Reversibility | post bronchodilator
Item
forced expiratory volume in one second (fev1) reversibility of greater than or equal to 12% following bronchodilator administration (2 puffs)
boolean
C3830088 (UMLS CUI [1,1])
C2599594 (UMLS CUI [1,2])
Informed consent
Item
patients who have given written informed consent
boolean
C0021430 (UMLS CUI [1])
Study Subject Participation Status
Item
participation in another clinical trial 1 month prior to study entry
boolean
C2348568 (UMLS CUI [1])
Systemic steroids | Use of
Item
use of systemic corticosteroids 2 weeks prior to study entry
boolean
C2825233 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
Communicable Diseases | Lower respiratory tract infection | Tuberculosis, Pulmonary | Mycoses
Item
patients with general infection, lower respiratory infection, pulmonary tuberculosis and fungal infection 1 month prior to study entry
boolean
C0009450 (UMLS CUI [1])
C0149725 (UMLS CUI [2])
C0041327 (UMLS CUI [3])
C0026946 (UMLS CUI [4])
Hospitalization | exacerbation acute
Item
hospitalization due to acute exacerbation 3 months prior to study entry
boolean
C0019993 (UMLS CUI [1,1])
C0743630 (UMLS CUI [1,2])
Inhaled steroids | Theophylline | Adrenergic beta-2 Receptor Agonists | Cromolyn Sodium | Leukotriene Antagonists | Anticholinergic Agents
Item
patients cannot stop using forbidden drugs which include inhaled corticosteroid, theophylline, long-term β2 agonist, sodium cromoglicate, leukotrienes antagonist and anticholinergic drug
boolean
C2065041 (UMLS CUI [1])
C0039771 (UMLS CUI [2])
C2936789 (UMLS CUI [3])
C0012694 (UMLS CUI [4])
C0595726 (UMLS CUI [5])
C0242896 (UMLS CUI [6])
Hypersensitivity | Albuterol | Adrenal Cortex Hormones
Item
patients who are allergic to albuterol and corticosteroid
boolean
C0020517 (UMLS CUI [1,1])
C0001927 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0001617 (UMLS CUI [2,2])
Malignant Neoplasms | Cardiovascular Diseases | Liver diseases | Kidney Diseases | Hematological Disease
Item
patients with severe primary diseases such as cancer, cardiovascular system, liver, kidney and hematopoietic system diseases
boolean
C0006826 (UMLS CUI [1])
C0007222 (UMLS CUI [2])
C0023895 (UMLS CUI [3])
C0022658 (UMLS CUI [4])
C0018939 (UMLS CUI [5])
Wheeze | Tuberculosis, Pulmonary | Bronchiectasis | Heart failure
Item
wheeze caused by pulmonary tuberculosis, bronchiectasia and cardiac insufficiency
boolean
C0035508 (UMLS CUI [1,1])
C0041327 (UMLS CUI [1,2])
C0006267 (UMLS CUI [2])
C0018801 (UMLS CUI [3])
Hyperthyroidism
Item
patients with hyperthyroidism
boolean
C0020550 (UMLS CUI [1])
Mental disorders
Item
patients with mental illness, acrasia
boolean
C0004936 (UMLS CUI [1])
Pregnancy | Breast Feeding | Pregnancy, Planned
Item
female patients in pregnancy, lactation period and planning to get pregnant during the trial
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
Disorder | Study Subject Participation Status
Item
any significant disorder that in the investigator's opinion, might put the patients at risk or influence the study outcomes
boolean
C0012634 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
Contraindications | Acupuncture | Dermatitis, Atopic | Infective eczematoid dermatitis | Hemorrhagic Disorders
Item
acupuncture contraindications: serious allergic or infectious dermatitis and hemorrhagic diseases such as thrombocytopenic purpura and hemophilia
boolean
C0683526 (UMLS CUI [1,1])
C0001299 (UMLS CUI [1,2])
C0011615 (UMLS CUI [2])
C0085658 (UMLS CUI [3])
C0019087 (UMLS CUI [4])
C0857305 (UMLS CUI [5])
C0684275 (UMLS CUI [6])